On the other hand, regular prophylaxis with FVIII starts later, after patients are presented with target joints in adult haemophilia A. This treatment option is not intended to reverse the joint disability, but to delay the progression of joint disease by reducing the number of bleeding episodes to improve the patient’s quality of life. Here, F8 is linked to hemophilia A.